ADOC — Adocia SA Share News
0.000.00%
Last trade - 00:00- €82.83m
- €74.48m
- €1.48m
Brief: Eli Lilly Says Arbitration Panel Rules In Favor Of Co In Complaint Filed By Adocia
Brief: Adocia H1 Net Income Loss of EUR 13.0 Million
Brief: Adocia Initiates 3-Week Phase 1B Study Of ADO09
Brief: Adocia Q1 Revenue At 1.1 Million Euros
Brief: Adocia Announces Positive Topline Results For First Clinical Study Of ADO09
Brief: Adocia FY Revenue Up At 47.4 Million Euros
Brief: Adocia Announces Clinical Trial Evaluating BioChaperone Lispro
Brief: Adocia 9-Month Revenue Up At 44 Million Euros
Brief: Adocia Says Eli Lilly Filed Complaint Against Co In US
Brief: Adocia Announces Positive Topline Results For First Clinical Study Of Biochaperone® Pramlintide Insulin
Brief: Adocia Announces Update To Second Arbitration Against Eli Lilly & Co
Brief: Adocia Announces Update On First Phase Of Arbitration Against Eli Lilly
Brief: Adocia H1 Net Profit Up At 10.6 Million Euros
Brief: Adocia And Tonghua Dongbao Announce Global Supply Agreements
Brief: Adocia And Tonghua Dongbao Announce A Strategic Alliance For Biochaperone Combo And Biochaperone Lispro In China
Brief: Adocia Starts First-In-Human Clinical Study Of BioChaperone Pramlintide Insulin
Brief: Adocia Had Cash And Cash Equivalents Of EUR 27.6 Million On March 31
Brief: Adocia FY Operating Revenue Down At 27.2 Million Euros
Brief: Adocia Files Additional Arbitration Claims Against Eli Lilly & Company